Similar articles

• Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.

  Singh L, Lewis AS, Field MJ, Hughes J, Woodruff GN. Singh L, et al. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1130-3. doi: 10.1073/pnas.88.4.1130. Proc Natl Acad Sci U S A. 1991. PMID: 1996314 Free PMC article.
• [Cholecystokinin and its antagonists: effects on digestive motility].

  Bruley des Varannes S, Cloarec D, Dubois A, Galmiche JP. Bruley des Varannes S, et al. Gastroenterol Clin Biol. 1991;15(10):744-57. Gastroenterol Clin Biol. 1991. PMID: 1816015 Review. French. No abstract available.
• [Gastrin-/CCK-B antagonists are neuropharmacological tools].

  Oreland L. Oreland L. Lakartidningen. 1995 Feb 8;92(6):531-2. Lakartidningen. 1995. PMID: 7853937 Swedish. No abstract available.
• 'Anxiolytic' effect of CCK-antagonists on plus-maze behavior in mice.

  Rataud J, Darche F, Piot O, Stutzmann JM, Böhme GA, Blanchard JC. Rataud J, et al. Brain Res. 1991 May 10;548(1-2):315-7. doi: 10.1016/0006-8993(91)91139-r. Brain Res. 1991. PMID: 1868342
• Cholecystokinin and panic disorder: past and future clinical research strategies.

  Bradwejn J, Koszycki D. Bradwejn J, et al. Scand J Clin Lab Invest Suppl. 2001;234:19-27. Scand J Clin Lab Invest Suppl. 2001. PMID: 11713976 Review.